Evidence map›Paper›PMID 36212813›Full record

ArticleFrontiers in microbiology2022

Genome-wide analysis reveals the emergence of multidrug resistant

Ying Zhang, Danhua Li, Qun Yan, Ping Xu, Wei Chen, Hongya Xin, Dengshu Wu, Mingxiang Zhou, Yajing Xu, Ao Zhang and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Frontiers in cellular and infection microbiology · 2025
    Article
  2. A novel pathogenic species of genusFrontiers in cellular and infection microbiology · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ying ZhangDepartment of Hematology, Xiangya Hospital, Central South University, Changsha, China.
Danhua LiDepartmant of Scientific Affairs, Hugobiotech Co. Ltd., Beijing, China.
Qun YanDepartment of Laboratory Medicine, Xiangya Hospital, Central South University, Changsha, China.
Ping XuDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Wei ChenDepartment of Gastroenterology, Changsha Central Hospital, Changsha, China.
Hongya XinDepartment of Hematology, Xiangya Hospital, Central South University, Changsha, China.
Dengshu WuDepartment of Hematology, Xiangya Hospital, Central South University, Changsha, China.
Mingxiang ZhouDepartment of Laboratory Medicine, Xiangya Hospital, Central South University, Changsha, China.
Yajing XuDepartment of Hematology, Xiangya Hospital, Central South University, Changsha, China.
Ao ZhangDepartment of Hematology, Xiangya Hospital, Central South University, Changsha, China.
Wenjia WeiDepartment of Hematology, Xiangya Hospital, Central South University, Changsha, China.
Zhiping JiangDepartment of Hematology, Xiangya Hospital, Central South University, Changsha, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

genome comparisonsgenome sequencinghuman infectionmultidrug resistantsepsisStenotrophomonas acidaminiphilavirulence factors

Identifiers

PMID36212813
PMCPMC9537462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.